Making cardiovascular medical devices safer
Dr Anna Waterhouse is investigating how vital medical devices, such as those used in heart surgery, can be made safer for patients.
HRI investigates link between AstraZeneca COVID-19 vaccine and blood clots
In an Australian first, a pilot study will seek to find biomarkers for blood clot risks in patients who have been given the AstraZeneca COVID-19 vaccine.
Global media interest in HRI’s world-first stroke drug trial
HRI researchers led by Professor Shaun Jackson have developed an anti-clotting drug that offers new hope to stroke sufferers.
Groundbreaking world-first trial offers new hope to stroke sufferers
HRI's top stroke experts are leading a world-first trial which could be a game-changer when it comes to debilitating strokes.
Dr Jessica Maclean awarded THANZ grant
Dr Jessica Maclean has been awarded a THANZ Scientific & Education Trust Grant to further investigate novel antiplatelet strategies to enhance stroke treatment.
Dr Ashish Misra awarded second Perpetual IMPACT grant
Dr Ashish Misra was recently awarded his second Perpetual IMPACT grant. Dr Misra’s research focuses on improved understanding and potential treatment of atherosclerosis.
When irregular heartbeat is something more: the WHF Roadmap on Atrial Fibrillation
HRI’s Professor Ben Freedman has co-chaired a significant update to the World Heart Federation Roadmap on Atrial Fibrillation.
Dr Melissa Farnham awarded Kirby Foundation grant
Dr Melissa Farnham has been awarded a Kirby Foundation grant to research how obstructive sleep apnoea causes disease.
Research to help prevent people dying of heart attack faces a funding shortfall
Researchers at HRI are appealing to the public to help fund research that could prevent thousands dying of heart attack each year.